A recombinant avipoxvirus HIV-1 vaccine expressing interferon-gamma is safe and immunogenic in macaques

Citation
Sj. Kent et al., A recombinant avipoxvirus HIV-1 vaccine expressing interferon-gamma is safe and immunogenic in macaques, VACCINE, 18(21), 2000, pp. 2250-2256
Citations number
17
Categorie Soggetti
Veterinary Medicine/Animal Health",Immunology
Journal title
VACCINE
ISSN journal
0264410X → ACNP
Volume
18
Issue
21
Year of publication
2000
Pages
2250 - 2256
Database
ISI
SICI code
0264-410X(20000428)18:21<2250:ARAHVE>2.0.ZU;2-M
Abstract
Complex recombinant fowlpoxvirus (rFPV) vaccines expressing both HIV-1 anti gens and type 1 cytokines could facilitate the induction of cellular immuni ty against HIV-1. A single rFPV expressing both HIV-1gag/pol and human inte rferon-gamma (FPVgag/pol-IFN gamma) was constructed and assessed as a thera peutic vaccine for safety and immunogenicity in macaques (Macaca nemestrina ) previously infected with HIV-1. FPV gag/pol-IFN gamma vaccinations were s afe and enhanced T cell proliferative responses to Gag antigens (but not co ntrol tetanus antigens). Enhanced CTL responses to gag/pol antigens were al so observed following IFN gamma expressing vaccinations. Since cellular imm unity may be critical to controlling or preventing HIV-1 infection, these o bservations suggest that avipox vectors co-expressing IFN gamma should be f urther evaluated as therapeutic or preventive HIV-1 vaccines. (C) 2000 Else vier Science Ltd. All rights reserved.